Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology in a COVID & Post-COVID World

Christopher Phillips, MD  |  May 11, 2020

In general, we need to consider the possibility that this crisis may lead to a winter or even a mini-ice age, in which the economic impact may last several years, as opposed to a blizzard that we can weather and clean up from in a few months.3 Until there is sufficient herd immunity, an effective vaccine or both, we should expect viral circulation that may lead to ongoing regional outbreaks, leading in turn to regional re-introduction of distancing protocols, even after initial restrictions are lifted.

Mitigating Losses & Planning for Post-COVID Remote Care
What factors may impact current practice health and what lingering impacts may ACR member practices see when the COVID-19 crisis abates? The ability to continue providing evaluation and management (E/M) services through the crisis is critical.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many of us have learned telehealth on the fly. We all have frustrating stories, which usually revolve around poor internet connections or dropped calls. However, I suspect many of us, if we are honest, would admit we have learned this skill more easily than we imagined.

We have the aid of the Centers for Medicare & Medicaid Services (CMS), which is reimbursing for audiovisual telehealth visits conducted with the patient in their home, across state lines and even with non-HIPAA-compliant modalities.4 (How many iPhone users have fallen back on FaceTime when the default platform failed? I am guilty as charged.)

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Fortunately, most commercial payers have followed suit and are paying for these services at office visit rates. The ACR and other groups have advocated coverage for audio-only encounters at standard E/M rates during the current crisis, because so many of our patients lack internet connectivity to support a video feed. Just as I finalized this document, word came that CMS has listened and is providing audio-only payment parity. (Reminder: Advocacy works!)

The U.S. Department of Health & Human Services (HHS) has given guidance to states suggesting they eliminate barriers to interstate telehealth services.5,6 However, state regulations remain a patchwork quilt, with some allowing carte blanche interstate care, some denying it and others requiring emergency licensure.7

Getting a taste of telehealth, some of our patients like it. When this crisis is over, be prepared for some patients to continue to request remote service. Will it be available to them? If CMS and commercial payers continue to reimburse telehealth at standard E/M rates and allow patients to be seen from their home, expect telehealth to remain popular.8

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Practice Support Tagged with:COVID-19Dr. Chris Phillipstelehealth

Related Articles

    Telehealth Brings Opportunities to Enhance Patient Care

    December 8, 2022

    During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences